A Study of BGB-11417 in Participants With Myeloid Malignancies
- Status
- RECRUITING
- Phase
- PHASE1/PHASE2
Clinical Trials Related to Myelodysplastic Syndromes
Related studies linked through entity extraction aliases.
Safety and Efficiency of γδ T Cell Against Hematological Malignancies After Allo-HSCT
- Status
- UNKNOWN
- Phase
- PHASE1/PHASE2
A Telehealth Advance Care Planning Intervention for Older Patients With Acute Myeloid Leukemia and Myelodysplastic Syndrome
- Status
- COMPLETED
- Phase
- NA
Pre-emptive Therapy With DEC-C to Improve Outcomes in MDS Patients With Measurable Residual Disease Post Allogeneic Hematopoietic Cell Transplant
- Status
- RECRUITING
- Phase
- PHASE1/PHASE2
A Study of CFI-400945 With or Without Azacitidine in Patients With AML, MDS or CMML
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE1/PHASE2
Treatment of MDS/AML Patients With an Impending Hematological Relapse With AZA or ATA and Pevonedistat
- Status
- COMPLETED
- Phase
- PHASE2
Haploinsufficiency of the RBM22 and SLU7 Genes in Del(5q) Myelodysplastic Syndromes
- Status
- UNKNOWN
- Phase
- N/A
IS-free Treg HaploHCT
- Status
- RECRUITING
- Phase
- PHASE1
Analysis of Risk in MDS Over Time - Comparison of Treated vs Untreated Patients
- Status
- COMPLETED
- Phase
- N/A
CPX-351 as a Novel Approach for the Treatment of Older Patients With AML and MDS
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
APR-548 in Combination With Azacitidine for the Treatment of TP53 Myelodysplastic Syndromes (MDS)
- Status
- TERMINATED
- Phase
- PHASE1
Thrombosomes® in Bleeding Thrombocytopenic Patients Study
- Status
- TERMINATED
- Phase
- PHASE2
Effects of Prebiotics on Gut Microbiome in Patients Undergoing HSCT
- Status
- COMPLETED
- Phase
- NA
IFN-γ to Treat Acute Myeloid Leukemia (AML) and Myelodysplastic Syndrome (MDS) That Has Relapsed After Allogeneic Hematopoietic Stem Cell Transplantation
- Status
- COMPLETED
- Phase
- EARLY_PHASE1
CD8 Depleted, Non-engrafting, HLA Mismatched Unrelated Infusion With MDS and Secondary AML
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
A Study of JNJ-74856665 in Participants With Acute Myeloid Leukemia (AML) or Myelodysplastic Syndrome (MDS)
- Status
- COMPLETED
- Phase
- PHASE1
Treatment of High Risk Myelodysplastic Syndromes (MDS) Not Candidates for Allogeneic Transplantation of Hematopoietic Progenitors (ALO-HSCT)
- Status
- UNKNOWN
- Phase
- N/A
Molecular Mechanisms of Disease Relapse After Allogenic Stem Cell Transplantation in MDS Patients
- Status
- RECRUITING
- Phase
- NA
To Assess the Safety and Tolerability of INCB000928 in Participants With Myelodysplastic Syndromes or Multiple Myeloma
- Status
- TERMINATED
- Phase
- PHASE1/PHASE2
Study to Evaluate the Safety and Tolerability of EP0042
- Status
- RECRUITING
- Phase
- PHASE1/PHASE2